During the past decade, Podlaskie Centrum Psychogeriatrii conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 14 clinical trials were completed, i.e. on average, 51.9% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 12 clinical trials were completed. i.e. 109.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Podlaskie Centrum Psychogeriatrii" #1 sponsor was "Boehringer Ingelheim" with 7 trials, followed by "Hoffmann-La Roche" with 5 trials sponsored, "AstraZeneca" with 3 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored and "Biogen" with 3 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Podlaskie Centrum Psychogeriatrii" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "APCER Life Sciences" with 1 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "KCAS Bio" with 1 trials as a collaborator and "PharmaConsulting Group" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Podlaskie Centrum Psychogeriatrii" are "Alzheimer's Disease" (12 trials), "Alzheimer Disease" (10 trials), "Schizophrenia" (3 trials), "Alzheimer´s Disease" (1 trials) and "Bipolar Disorder" (1 trials). Many other conditions were trialed in "Podlaskie Centrum Psychogeriatrii" in a lesser frequency.

Most popular intervention types in "Podlaskie Centrum Psychogeriatrii" are "Drug" (30 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (25 trials), "Gantenerumab" (3 trials), "Lanabecestat" (3 trials), "BI 409306" (2 trials) and "BI 425809 dose 1" (2 trials). Other intervention names were less common.

The vast majority of trials in "Podlaskie Centrum Psychogeriatrii" are 30 trials for "All" genders.

Currently, there are NaN active trials in "Podlaskie Centrum Psychogeriatrii". undefined are not yet recruiting, 4 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Podlaskie Centrum Psychogeriatrii, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Podlaskie Centrum Psychogeriatrii, 0 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".